U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 217202

RAPIBLYK (LANDIOLOL HYDROCHLORIDE)
EQ 280MG BASE/VIAL
Marketing Status: Prescription
Active Ingredient: LANDIOLOL HYDROCHLORIDE
Proprietary Name: RAPIBLYK
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 280MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N217202
Product Number: 001
Approval Date: Nov 22, 2024
Applicant Holder Full Name: AOP ORPHAN PHARMACEUTICALS AG
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top